HOME >> BIOLOGY >> NEWS
UF Researcher Designs Pill To Control Mosquitoes

ecause they were not digesting, so then we knew we had a diet pill, not a birth control pill.

"Fortunately, now we can synthesize the hormone, so we don't have to use 100,000 ovaries for each batch anymore," Borovsky said.

The synthesized hormone is inexpensive, as is chlorella, which is found and produced worldwide. Chlorella, in fact, turns out to be the perfect ride for the mosquito hormone, because it can be freeze-dried and stored for long periods and then brought back to life as the deadly diet pill.

The mosquito fen-phen is benign environmentally. Unlike DDT and some other pesticides, it does not alter the environment in any way, except for poisoning the larval lunch. Mosquitoes that feed on the hormone-laced chlorella starve to death within 72 hours.

"This is a natural bullet that we can use in the environment because the hormone doesn't stay in the environment," Borovsky said. "The chlorella stops producing the hormone within three weeks."

That's by design, Borovsky said. If the hormone were incorporated into the chlorella genome and chlorella continued to produce the hormone, making it omnipresent in the environment, mosquitoes could become resistant to it. But the hormone sits outside the genome, and after the third division of the chlorella it no longer can be detected.

Of course, Borovsky points out, if mosquitoes become resistant to their own reproductive hormone that could have unknown adverse consequences for them as well.

"We have to stay a step ahead of them or outsmart them all over again," Borovsky said.

In the decade since he began work on the pill, Borovsky has made believers out of even the most ardent doubters.

"Ten years ago, everybody was laughing at us, but now they are taking us seriously," Borovsky said. "Eight years ago, at a Vancouver meeting, a colleague harshly criticized this work. He just did not believe it."

The next step, Borovsky says, is to develop diet pills for infamous agricultural pests. Curren
'"/>

Contact: Cindy Spence
crsp@gnv.ifas.ufl.edu
352-392-1773
University of Florida
2-Dec-1997


Page: 1 2 3

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... and GAITHERSBURG, Md. ... MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics ... of a definitive agreement for the merger of ... current investors include Novartis Venture Fund, HealthCap, Truffle ... be a fully-integrated and diversified immunotherapeutics company with ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... services spanning the full spectrum of drug and device development, and Prism ... pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has ...
Breaking Biology Technology:
Cached News: